Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

Lung Cancer Manag. 2020 Feb 25;9(2):LMT26. doi: 10.2217/lmt-2019-0016.

Authors

Alain Gelibter¹, Mario Occhipinti¹, Simona Pisegna¹, Alessio Cortellini^{2

3}, Enrico Cortesi¹, Paolo Marchetti^{1

4}

Affiliations

¹ Medical Oncology Unit, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
² Medical Oncology Unit, St. Salvatore Hospital, L'Aquila, Italy.
³ Department of Biotechnological & Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
⁴ U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.

No abstract available

Keywords: BMI; NSCLC; PD-1; cancer; immune checkpoint inhibitors; immune system; immunotherapy; obesity; prognostic clinical marker.

Publication types

Editorial